$91.4 million bought by Armenian banks in one week

YEREVAN, December 7. /ARKA/. Twenty-one Armenia-based commercial banks bought a total of $91.4 million from the local foreign exchange intra-market from November 30 to December 4 at the weighted average exchange rate of 482.13 drams per $1, the press service of the Central Bank of Armenia said.

It said also in the same time span they bought 8.1 million Euros and about 1 billion Russian rubles at weighted average exchange rates of 512.98 per one Euro and 7.18 drams per one ruble.

The banks also sold $100.2 million, €10.8 million and 516.9 million Russian rubles at the weighted average exchange rates of 484.47 drams, 515.87 drams and 7.28 drams respectively.

Besides, from November 23 to 29 the banks extended about 36.3 billion drams worth loans in the Armenian national currency and $41.3 million loans in US currency. ($1 – AMD 484.43). —0—-

spot_img

POPULAR

Record growth of Armenia’s reserves to $6.9 billion in June provided a buffer amid heightened geopolitical risks – S&P

Armenia's international reserves increased by approximately 40% year-on-year to a record $6.9 billion in June 2026, helping to strengthen the country's external reserves despite heightened geopolitical risks, according to a report by international rating agency S&P Global Ratings.

“Unisport” Competes in the UEFA Futsal Champions League

Unisport Futsal Club, established with the sponsorship of Unibank, will host UEFA Futsal Champions League 2026/27 preliminary round matches in Yerevan on August 26, 27 and 29.

S&P affirms Armenia’s ratings, maintaining a positive outlook

The international rating agency S&P Global Ratings affirmed the long- and short-term sovereign ratings of the Republic of Armenia at 'BB-/B', maintaining a positive outlook, the Ministry of Finance reported.

Armenian banks will provide citizens with account statements free of charge

Individuals in Armenia will be able to receive free electronic statements from commercial banks about their bank accounts, their balances, and the presence or absence of mutual obligations with the bank.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img